Posted on February 24, 2022May 3, 2022Gunze MedicalUncategorizedGunze Launches TENALEAF™ Absorbable Adhesion Barrier in Japantailored to medical professionals to improve patient clinical outcome…Read More
Posted on September 16, 2021May 3, 2022Gunze MedicalUncategorizedAnnouncing the use of Gunze’s meniscal repair biodegradable scaffolds for a clinical trial to improve the outcome of medial meniscal injury patients at Osaka Medical and Pharmaceutical University…Read More
Posted on September 16, 2021September 16, 2021SysAdminUncategorizedLaunch of Gunze’s U.S. Medical Division Website…Read More
Posted on September 24, 2020June 9, 2021SysAdminUncategorizedGunze provides biodegradable scaffolds for TEVG clinical trial to be conducted at the Abigail Wexner Research Institute at Nationwide Children’s Hospital to improve pediatric patient clinical outcome…Read More
Posted on September 24, 2020May 3, 2022SysAdminUncategorizedGunze Enters into Exclusive Supply and Distribution Agreement with Misonix for TheraGenesis® Bilayer Wound Matrix in U.S. Market…Read More
Posted on April 29, 2020May 3, 2022SysAdminUncategorizedPELNAC® Bilayer Wound Matrix Receives U.S. Food and Drug Administration (FDA) Clearance…Read More
